ADIPOQ and breast cancer: Genetic variants of ADIPOR1 and its ligand adiponectin have been associated with increased risk of breast cancer [35] and circulating adiponectin levels are inversely correlated with breast cancer in post-menopausal women [15], while higher levels of adiponectin are associated with improved survival in obese, insulin-resistant breast cancer patients [36].